Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 23.03.2026 3 Acta Haematol 4 Am J Hematol 6 Ann Hematol 1 Biochem Biophys Res Commun 1 Blood 3 Bone Marrow Transplant 9 Br J Haematol 1 Cancer Chemother Pharmacol 1 Cancer Res 1 Eur J Haematol 3 Exp Hematol 1 Leuk Lymphoma 3 Leuk Res 2 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. FROST M, Subbiah V, Cuglievan B, Garcia MB, et al
   Reconsidering Asparaginase in Leukemia Therapy.
   Acta Haematol. 2026 Mar 13:1-5. doi: 10.1159/000551486.
   PubMed        
   
   
2. TUNGJITVIBOONKUN S, Daran L, Unsuwan S
   Chronic Myeloid Leukemia (CML): historical perspective, pathophysiology, and treatment advances.
   Acta Haematol. 2026 Mar 13:1-28. doi: 10.1159/000551493.
   PubMed         Abstract available
   
   
3. TAKAHASHI S
   Differentiation Therapy in Acute Myeloid Leukemia: Advances in Phenotypic Screening and CRISPR-based Functional Genomics.
   Acta Haematol. 2026 Mar 13:1-36. doi: 10.1159/000551445.
   PubMed         Abstract available
   
   

   
   Am J Hematol

4. HAAKSMA LH, Reuvekamp T, Croese KJ, Muijtjens M, et al
   Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.
   Am J Hematol. 2026 Mar 19. doi: 10.1002/ajh.70291.
   PubMed        
   
   
5. KANTARJIAN H, Chifotides HT, Haddad FG, Jabbour E, et al
   The Care and Cure of the Leukemias in 2026.
   Am J Hematol. 2026;101:807-831.
   PubMed         Abstract available
   
   
6. GANGAT N, Warraich M, Kumar S, Fatima M, et al
   TP53 Mutations and Circulating Blasts >/= 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent.
   Am J Hematol. 2026;101:866-871.
   PubMed         Abstract available
   
   
7. LECORNEC N, de Fontbrune FS, Forcade E, Garcon L, et al
   Hematologic Landscape of Adult Patients With Diamond-Blackfan Anemia Syndrome.
   Am J Hematol. 2026 Jan 7. doi: 10.1002/ajh.70197.
   PubMed         Abstract available
   
   

   
   Ann Hematol

8. PEI W, Zhang X, Du LA, Liu Z, et al
   Role of cystatin C in predicting the risk of hypermethotrexemia and kidney injury after high-dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.
   Ann Hematol. 2026;105:176.
   PubMed         Abstract available
   
   
9. WANG Y, Xiao Y
   CLL-1: An emerging target for immunotherapy in acute myeloid leukemia.
   Ann Hematol. 2026;105:179.
   PubMed         Abstract available
   
   
10. MORELLI F, Linari S, Rapolla CM, Attanasio M, et al
    Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia.
    Ann Hematol. 2026;105:177.
    PubMed         Abstract available
    
    
11. LI Y, Fan Z, Wang LN, Tang YL, et al
    Incidence, clinical features and risk factors of interstitial pneumonia in children with acute lymphoblastic leukemia.
    Ann Hematol. 2026;105:180.
    PubMed         Abstract available
    
    
12. HASSANI MA, Huang D, Gao Y, Zhang X, et al
    The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations.
    Ann Hematol. 2026;105:178.
    PubMed         Abstract available
    
    
13. GURER T, Gunay UB, Kilic B, Akkan Suzan A, et al
    Restless legs syndrome in chronic myeloid leukemia: an overlooked condition with a significant impact on health-related quality of life.
    Ann Hematol. 2026;105:190.
    PubMed         Abstract available
    
    

    
    Biochem Biophys Res Commun

14. LI W, Sun M, Yao B, Li X, et al
    FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse.
    Biochem Biophys Res Commun. 2026;809:153493.
    PubMed         Abstract available
    
    

    
    Blood

15. MIAO H, Wu T, Purohit T, Chen D, et al
    Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models.
    Blood. 2026 Mar 18:blood.2025031201. doi: 10.1182/blood.2025031201.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

16. SZMIT Z, Lucchini G, Bertaina A, Galimard JE, et al
    Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.
    Bone Marrow Transplant. 2026 Mar 19. doi: 10.1038/s41409-026-02797.
    PubMed         Abstract available
    
    
17. WU N, Kong J, Lv M, Mo XD, et al
    Donor age >/=50 years combined with donor-CI >/=3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2026 Mar 18. doi: 10.1038/s41409-026-02844.
    PubMed        
    
    
18. LEE JH, Ahn J, Kwag D, Min GJ, et al
    Relapse patterns focusing on central nervous system involvement after allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2026 Mar 14. doi: 10.1038/s41409-026-02807.
    PubMed         Abstract available
    
    

    
    Br J Haematol

19. GU J, Wang J, Liu L, Zhang Y, et al
    Integrated prognostic value of MRD and cytogenetics in adolescent and adult B-cell acute lymphoblastic leukaemia.
    Br J Haematol. 2026;208:954-964.
    PubMed         Abstract available
    
    
20. KIRK A, James B, Feltbower RG, Mushtaq T, et al
    Bone mineral density and vertebral fractures in teenage and young adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma: A report from the British OsteoNecrosis Study (BONES).
    Br J Haematol. 2025 Dec 18. doi: 10.1111/bjh.70286.
    PubMed         Abstract available
    
    
21. BOUDRY A, Chevillon F, Marceau-Renaut A, Braun T, et al
    Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study.
    Br J Haematol. 2026;208:897-904.
    PubMed         Abstract available
    
    
22. UENO T, Yoshimitsu M, Sameshima M, Nagano T, et al
    Clinical features and incidence of central nervous system involvement in patients with adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2026 Jan 5. doi: 10.1111/bjh.70301.
    PubMed         Abstract available
    
    
23. BRECCIA M, Giai V, Rosso T, Pregno P, et al
    Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study.
    Br J Haematol. 2026;208:974-980.
    PubMed         Abstract available
    
    
24. VERBEEK MWC, Sanders MA, Grashof DGB, Hoogenboezem RM, et al
    The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia.
    Br J Haematol. 2026;208:883-896.
    PubMed         Abstract available
    
    
25. YI S, Cao J, Feng R, Zhou K, et al
    A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
    Br J Haematol. 2026 Jan 22. doi: 10.1111/bjh.70334.
    PubMed         Abstract available
    
    
26. FLEISCHMANN M, Hansen O, Voigtlander D, Bechwar J, et al
    Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations.
    Br J Haematol. 2026;208:905-915.
    PubMed         Abstract available
    
    
27. MACPHAIL A, Loke J, Houston BL, Dendle C, et al
    Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice.
    Br J Haematol. 2026;208:981-991.
    PubMed         Abstract available
    
    

    
    Cancer Chemother Pharmacol

28. RAHA SJ, Bhatia P, Bansal D, Trehan A, et al
    Effect of high-dose methotrexate infusion duration on 48-hour drug levels and toxicity in children with acute lymphoblastic leukaemia: a quality-of-care study.
    Cancer Chemother Pharmacol. 2026;96:24.
    PubMed         Abstract available
    
    

    
    Cancer Res

29. HILGART E, Zhou W, Martinez-Montes E, Tryggvadottir R, et al
    DNA Methylation Stochasticity is Linked to Transcriptional Variability and Convergent Epigenetic Disruption Across Genetic Subtypes of Acute Myeloid Leukemia.
    Cancer Res. 2026 Mar 16. doi: 10.1158/0008-5472.CAN-25-5822.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

30. BRUZZESE A, Vigna E, Martino EA, Caserta S, et al
    Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs.
    Eur J Haematol. 2026 Mar 15. doi: 10.1111/ejh.70169.
    PubMed         Abstract available
    
    

    
    Exp Hematol

31. SHAH R, Kingston N, Fabbri G, Saeh J, et al
    Evaluation of dual BCL-2/BCL-XL inhibition in acute myeloid leukemia preclinical models with and without prior venetoclax therapy.
    Exp Hematol. 2026;156:105379.
    PubMed         Abstract available
    
    
32. LIU X, Zhang Y, Hua S, Shao X, et al
    Gremlin-1 promotes leukemic survival via PI3K/AKT signaling in infant MLL-AF4-positive B-cell acute lymphoblastic leukemia.
    Exp Hematol. 2026 Feb 25:105402. doi: 10.1016/j.exphem.2026.105402.
    PubMed         Abstract available
    
    
33. HAMED M, Kovecses O, McKeague M
    Current landscape of mRNA therapeutics for acute myeloid leukemia.
    Exp Hematol. 2026 Mar 17:105406. doi: 10.1016/j.exphem.2026.105406.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

34. SIMON F, Ligtvoet R, Furstenau M, Langerbeins P, et al
    Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2026 Mar 17:1-7. doi: 10.1080/10428194.2026.2634939.
    PubMed        
    
    

    
    Leuk Res

35. AMBINDER A, Levis M, Wang X, Pratz K, et al
    A real-world analysis of the impact of azole antifungal prophylaxis on outcomes in patients with newly diagnosed acute myeloid leukemia treated with venetoclax-based therapy.
    Leuk Res. 2026;164:108204.
    PubMed         Abstract available
    
    
36. VIEIRA MS, Marcondes NA, Rotta LN
    The emerging role of plasmacytoid dendritic cell proliferation in acute myeloid leukemia.
    Leuk Res. 2026;164:108198.
    PubMed         Abstract available
    
    
37. GOTO A, Iyama S, Yoshida M, Tatekoshi A, et al
    Emergence and continuous clonal evolution of a JAK2 exon 12-mutated myeloid clone after treatment for de novo acute myeloid leukemia.
    Leuk Res. 2026;163:108202.
    PubMed        
    
    

    
    Leukemia

38. BARRAL L, Lespinasse N, Martin Cardozo C, Jeanpierre S, et al
    Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance.
    Leukemia. 2026 Mar 18. doi: 10.1038/s41375-026-02904.
    PubMed         Abstract available
    
    
39. WOBST J, Ruge H, Senk S, Muller H, et al
    Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal origin.
    Leukemia. 2026 Mar 18. doi: 10.1038/s41375-026-02918.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum